1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legal & IP

Illumina Creeps Closer To Half-Billion-Dollar Fine

 
• By Barnaby Pickering

The sequencing giant could be pilloried in Europe and may have to pay a record-breaking fine.

Euros
• Source: Shutterstock

Illumina’s precarious acquisition of Grail could soon cost it dearly, with the Financial Timesreporting that it may be confronted with an enormous fine as early as next week in response to its decision to flout European regulators’ warnings.

Ignoring the European Commission on contested mergers and acquisition activities can cost a company up to 10% of its last-recorded revenue figures. For Illumina, which earned $4

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Policy & Regulation

Access To Library Tools Being Restored At US FDA

 
• By Sue Sutter and Derrick Gingery

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals and laid off librarians have not been reinstated.

FDA Announces Classifications On 9 Device Types

 
• By Elizabeth Orr

The US Food and Drug Administration has announced new classifications for eight device types that reached market via the de novo process, with most of the newly classified products in the diagnostics sector.

Medical Devices Not The Focus Of FDA’s Plans To Step Up Foreign Inspections, Expert Says

 
• By Brian Bossetta

The US FDA recently announced plans to carry out more unannounced inspections of foreign facilities. But those inspections will primarily target drug producers, with less attention and resources allocated to those making devices.